Prolotherapy for Ankle Pain 2026 | Podiatrist

Quick answer: Prolotherapy Ankle is a common foot/ankle topic that affects many patients. The 2026 evidence-based approach combines proper diagnosis, conservative-first treatment, and escalation only when needed. We treat this regularly at our Howell and Bloomfield Hills practices. Call (810) 206-1402.

https://www.youtube.com/watch?v=6NtFiSbUaRo

What Is Prolotherapy and How Does It Work?

Prolotherapy (proliferative injection therapy) uses hypertonic dextrose solution (typically 12.5–25% dextrose) injected into ligaments, tendons, and joint capsule to trigger a controlled inflammatory healing response. The mechanism: dextrose injection creates localized irritation and mild tissue damage, which stimulates release of growth factors (platelet-derived growth factor, transforming growth factor-β, insulin-like growth factor) that promote collagen synthesis and tissue repair in chronically weakened or degenerated connective tissue.

Prolotherapy differs from cortisone injections in its intent: cortisone suppresses inflammation to reduce pain; prolotherapy creates controlled inflammation to stimulate repair. This distinction makes prolotherapy most appropriate for chronic laxity conditions where tissue strengthening is the goal—not acute injuries where inflammation itself is the problem.

For ankle instability, prolotherapy targets the lateral ankle ligaments—primarily the anterior talofibular ligament (ATFL) and calcaneofibular ligament (CFL)—that have become chronically lax after repeated ankle sprains or traumatic tears. By injecting dextrose at the ligament-bone interface (enthesis), prolotherapy aims to induce fibroblast proliferation and new collagen formation that tightens and strengthens the lax ligaments.

The Evidence for Ankle Prolotherapy

The evidence base for prolotherapy in chronic ankle instability is growing and modestly positive, though limited by study quality compared to major pharmaceutical trials. Key studies: A systematic review (Hauser et al.) found significant improvement in ankle stability and pain scores in chronic ankle instability patients treated with dextrose prolotherapy series; a randomized controlled trial comparing prolotherapy to saline injection showed greater improvement in ATFL integrity on ultrasound in the prolotherapy group; and several case series report 70–80% patient satisfaction with prolotherapy for chronic ankle instability.

Prolotherapy is most appropriate when: ankle instability is chronic (12+ months); conservative rehabilitation has failed or plateaued; the patient wants to avoid surgical ligament reconstruction (Brostrom procedure); and initial response to a diagnostic dextrose injection is positive. A typical prolotherapy series involves 3–6 injections spaced 2–4 weeks apart, with ultrasound guidance for accuracy.

Limitations: prolotherapy is not covered by most insurance plans; the evidence base is smaller than for PRP or surgical options; results are variable; and significant time commitment (3–6 months for full course) is required. However, the safety profile is excellent—no documented serious adverse events from properly performed dextrose prolotherapy in the foot and ankle literature.

Prolotherapy vs. Other Ankle Instability Treatments

The treatment ladder for chronic ankle instability: (1) Physical therapy and neuromuscular rehabilitation is first-line—many patients with chronic instability have inadequate peroneal strength and proprioceptive deficit that can be addressed with targeted therapy; (2) Bracing with a lace-up functional ankle brace during higher-risk activities; (3) Prolotherapy for patients who have completed rehabilitation but retain mechanical laxity; (4) PRP injection—stronger regenerative stimulus than prolotherapy, more evidence, appropriate for more severe laxity; (5) Surgical Brostrom-Gould reconstruction—the gold standard for severe mechanical instability unresponsive to conservative and injection-based care.

Prolotherapy occupies a useful position between rehabilitation and surgical reconstruction for moderate ankle instability. For young athletes who want to avoid surgery but have exhausted physical therapy, prolotherapy offers a meaningful non-surgical option. For older, less active patients with mild-to-moderate instability, prolotherapy may provide sufficient functional improvement without surgical risk.

The key differentiator: patients with significant mechanical laxity documented on stress X-ray (>5mm talar tilt difference, >3mm anterior drawer difference vs. normal side) often need surgical reconstruction for definitive treatment. Prolotherapy is best suited for functional instability (complaints of giving way with preserved or borderline mechanical laxity) rather than severe structural laxity.

Dr. Tom's Product Recommendations